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Abstract
The prevention of the infectious diseases was accomplished long before there was any understanding of the
molecular biology of bacteria and viruses. As for cancer, the sharp drop in frequency of the once-commonest
lethal cancer, stomach cancer, was achieved without any contribution from biological research, and the current
drop in lung cancer is the end-result of the observation by epidemiologists that most lung cancer is caused by
smoking. So the basis for both these triumphs was essentially empirical and owed nothing to biological research.
This paper discusses how molecular biology can now offer the possibility of large-scale protection against cancer.
Article
Research into cancer has in the past been largely mana-
g e db yd o c t o r sa n dt h ee m p h a s i sh a st e n d e dt ob eo n
finding new treatments rather than on prevention. But it
is quite clear that life expectancy in the industrialised
world had almost doubled by the time the first antibio-
tics were discovered [1], and this must therefore have
been achieved by prevention of the major infectious dis-
eases rather than by devising better forms of treatment.
As for cancer, the two main successes against the com-
mon cancers, namely the declines in lung and stomach
cancer, were not achieved by treatment but by deliberate
or fortuitous prevention, respectively.
Cancers arise largely or wholly as the result of muta-
tion, each kind of cancer being commonly associated
with particular combinations of mutations in genes
known to be involved in the regulation of cellular beha-
viour [2]. Furthermore, the same genes are involved in
experimental carcinogenesis in mice. Recently it has
become possible to scan the entire genome of cancer
cells, and this has shown that the genomes of patients’
cancers usually differ by many hundreds of changes
from the genomes of the patients’ normal cells [3]. Inci-
dentally, the high mutation rate (and therefore versati-
lity) of cancer cells may explain why it has been so hard
to find a drug that kills all the cells in a patient’s cancer.
One of the major projects in cancer research is to look
for inherited mutations in human populations that raise
the risk of cancer, particularly the risk of breast cancer
because this is the common cancer that tends to run in
families. Unfortunately, apart from two mutant genes
long known to be associated with a high risk of breast
cancer, the search has shown that changes in a large
number of genes influence overall risk and so this
knowledge may have little practical application.
The early days of molecular genetics showed, however,
that you learn about the pathway to an end-result by
studying mutations that block that pathway and that
you may learn little or nothing from the mutations that
accelerate it. For example, early in the 20
th century it
was Garrod’s and Cunéot’s studies of the “inborn errors
of metabolism” that disclosed the pathway which breaks
down phenylalanine and tyrosine in humans [4] and
makes the pigments in mouse skin [5], and that was the
start of the science of molecular genetics. If we want to
learn about the pathway to cancer and perhaps learn
how to prevent people from developing cancer we
should be looking for mutations that lower the risk of
cancer rather than just those that raise risk.
The project could not easily be carried out in humans.
Although, there are hints that a few people may have a
lower risk of cancer than the average, the evidence is
unavoidably weak since only about 50% of the human
population develop cancer. But at least it is clear that
mice do vary in their susceptibility to experimental car-
cinogenesis [6] and that it is possible by selective
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lowered susceptibility [7]; (the latter exercise came to
nothing because, at the time, the main object was to
create mice with raised susceptibility so that they could
be used as a tester strain for carcinogens). The present
project should therefore start with a study in mice and
then, if successful, be extended to humans. (A possible
shortcut would be to look in the existing data bases for
alleles that are significantly more common in old people
who have never developed cancer [8].
Returning now to the origins of humankind, it is clear
that our world is far less demanding and dangerous
than it used to be, and the best of all possible genomes
in ancient times is unlikely to be the best for today. No
doubt the same is true for the pampered laboratory
mouse. Therefore a search for resistance genes, first in
mice and then in humans, seems a reasonable project.
In recent years it has become even more plausible,
because a new ingredient has emerged for understand-
ing the workings of natural selection. Many years ago,
bacteria were observed to react to stress by increasing
their mutation rate [9]. This “SOS response” as it was
called [10] was found to be dependent on the activity of
certain genes involved in DNA repair that are not
involved in the normal growth and low mutation rate of
bacteria. Later these findings were extended to yeast and
mammalian cells, and a whole host of genes are now
known whose products cope with all kinds of damage
(in particular, the damage caused by heat-shock), includ-
ing some protection against damaged and defective pro-
teins. From the point of view of cancer research, the
most important feature of the response is that once
induced, for example by DNA damage, it can switch on
the high mutation rate for several cell generations [11].
And this, incidentally, offers us a new way of interpret-
ing the strange stages observed in experimental carcino-
genesis – namely, that “initiation” by mutagenic
carcinogens may be simply the induction of what in
mammalian cells is usually called the heat-shock
response, and that the subsequent prolonged process of
“promotion” is simply the disruption of tissue organiza-
tion which then allows the incursion of natural selection
and the preferential survival of the fittest mutants.
Speculations about the mechanisms underlying biologi-
cal processes usually prove to be vast oversimplifications,
because they underestimate the complexity of biology.
Happily, the present argument is not dependent on cor-
rectness of interpretation. For it is already clear that inacti-
vation of the heat-shock response (by knocking out both
copies of the gene, HSF1, that switches on the response)
greatly lowers the susceptibility of mice to induced and
spontaneous cancers, without at the same time much
affecting their viability and longevity [12]. So we do know
that polymorphisms can exist that lower the risk of cancer,
a n di ti si m a g i n a b l et h a to n ed a ys o m ef o r mo fg e n e t i c
manipulation may be used as a general preventive measure
against most cancers. (A possible shortcut to such a
l e n g t h yp r o g r a mc o u l db et ou s et h es e q u e n c i n gd a t a
accumulated in the search for alleles that raise susceptibil-
ity and look for polymorphisms in human HSF1 that are
rare in old people who have had cancer).
Conclusion
There is, I think, an important message from this very
brief history. The prevention of the infectious diseases
was accomplished long before there was any under-
standing of the molecular biology of bacteria and
viruses. As for cancer, the sharp drop in frequency of
the once-commonest lethal cancer, stomach cancer, was
achieved inadvertently and without any contribution
from biological research, and the current drop in lung
cancer is the much-delayed end-result of the observation
by epidemiologists that most lung cancer is caused by
smoking. So the basis for both these triumphs was
essentially empirical and owed nothing to biological
research. Perhaps now the time has come for modern
molecular biology to make the breakthrough.
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